Sukumar Nagendran

Companies

• Taysha Gene Therapies, Inc.President Jan 4, 2023 to now¹
• Taysha Gene Therapies, Inc.Board member Sep 23, 2020 to now²
• Solid Biosciences Inc.Board member Sep 13, 2018 to now³
• Immunovant, Inc.Board member May 9, 2019 to May 9, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TGTaysha Gene Therapies, Inc. TSHA936,410 shares⁵$3.5M at $3.77Jul 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 10, 2026Sold 200,000 shares at $6.24 of Taysha Gene Therapies, Inc.⁵
• Apr 10, 2026Sold 200,000 shares at $4.46 of Taysha Gene Therapies, Inc.⁶
• Apr 10, 2026Exercised options 19,021 shares at $1.71 of Taysha Gene Therapies, Inc.⁶
• Jan 26, 2026Sold 26,918 shares at $4.61 of Taysha Gene Therapies, Inc.⁷
• Jan 23, 2026Sold 89,132 shares at $4.75 of Taysha Gene Therapies, Inc.⁷
• Jan 12, 2026Granted 427,000 shares of Taysha Gene Therapies, Inc.⁸
• Jan 12, 2026Sold 200,000 shares at $4.71 of Taysha Gene Therapies, Inc.⁸
• Jan 12, 2026Exercised options 88,676 shares at $1.71 of Taysha Gene Therapies, Inc.⁸
• Jan 12, 2026Exercised options 111,324 shares at $0.70 of Taysha Gene Therapies, Inc.⁸
• Dec 1, 2025Sold 260,047 shares at $4.51 of Taysha Gene Therapies, Inc.⁹
• Dec 1, 2025Exercised options 260,047 shares at $1.71 of Taysha Gene Therapies, Inc.⁹
• Nov 28, 2025Sold 110,125 shares at $4.75 of Taysha Gene Therapies, Inc.⁹
• Nov 28, 2025Exercised options 39,953 shares at $1.71 of Taysha Gene Therapies, Inc.⁹
• Nov 28, 2025Exercised options 70,172 shares at $0.70 of Taysha Gene Therapies, Inc.⁹
• Sep 10, 2025Sold 200,000 shares at $3.23 of Taysha Gene Therapies, Inc.¹⁰
• Sep 10, 2025Exercised options 41,150 shares at $0.70 of Taysha Gene Therapies, Inc.¹⁰
• Aug 21, 2025Sold 57,054 shares at $2.85 of Taysha Gene Therapies, Inc.¹¹
• Jan 2, 2025Granted 324,500 shares of Taysha Gene Therapies, Inc.¹²
• Jan 2, 2024Granted 863,617 shares of Taysha Gene Therapies, Inc.¹³
• May 16, 2023Bought 5,000 shares at $0.68 of Taysha Gene Therapies, Inc.¹⁴
• Feb 2, 2022Bought 10,000 shares at $8.01 of Taysha Gene Therapies, Inc.¹⁵